OMEW : Outcomes Management Educational Workshops

What's New in Vaccines

Statement of Need

The advantages of providing a meningococcal booster utilizing the improved conjugate technology formulation will be explained. Similarly, the disease burden and benefits derived from acellular pertussis vaccine boosters to teenagers and adults will provide the audience with an understanding for a recommendation for universal use.

The rationale and recommendations for use for newly licensed vaccines will be reviewed to include the new meningococcal conjugate vaccines and the new tetinus-diphtheria-acellular pertussis vaccine for adolescents. Also, vaccines with anticipated FDA approval will be discussed.

Educational Objectives:

Recognize the value of and reasoning behind endorsement of use of meningococcal conjugate vaccines.
Define the need for pertussis booster vaccinations of adolescents & adults in the U.S.
Know the national recommendations regarding use of meningococcal & pertussis vaccines in the U.S.
Identify risk factors in acquiring HPV infection

Exciting update of newly licensed vaccines
Overview of vaccines on the horizon
Option of interactive Audience Response System
Presented and developed by nationally recognized opinion leaders

Michael E. Pichichero, MD
Professor of Microbiology/Immunology, Pediatrics and Medicine
University of Rochester Medical Center
Department of Microbiology/Immunology
Rochester, NY

*Workshop Faculty*
Mark Blatter, MD	Colin Marchant, MD
Stan Block, MD	Stephen Pelton, MD
Janet Casey, MD	Michael Pichichero, MD
Candice Johnson, MD	Keith Reisinger, MD
Christopher Harrison, MD	Lawrence Sher, MD
James Hedrick, MD	Ellen Wald, MD
Jerome Klein, MD

*You will need the free Adobe Acrobat Reader to view the Brochure.
Click here to download.